|
2024
|
Invention
|
An improved process for manufacturing of valproic acid and/or its salt. The present invention pro... |
|
|
Invention
|
Protein for treatment of inflammatory diseases.
The present invention relates to a lectin for us... |
|
|
Invention
|
A stable pharmaceutical composition and process for preparing thereof. The present invention prov... |
|
2023
|
Invention
|
Proteins with minimal n-terminal initiator methionine. The present invention relates to a recombi... |
|
|
Invention
|
Substituted tricyclic compounds and their use in rheumatoid arthritis. 11 is -NRaRb211010 alkyl g... |
|
|
Invention
|
Substituted tricyclic compounds and their use in covid-19. 1 1 is -NRaRb211010 alkyl group; Raand... |
|
|
Invention
|
Substituted tricyclic compounds and their use in ulcerative colitis. 1 1 is -NRaRb2 11010 alkyl g... |
|
2022
|
Invention
|
Recombinant protein for sars-cov2 disease.
The present invention relates to the protein for trea... |
|
|
Invention
|
Recombinant protein for treating sars-cov2 disease. Sclerotium rolfsiiSclerotium rolfsiiSclerotiu... |
|
|
Invention
|
Recombinant glycan binding proteins and its use.
The present disclosure provides a modified prot... |
|
|
Invention
|
Lectin-drug conjugates. The present disclosure relates to protein-drug conjugates. The present di... |
|
|
Invention
|
Recombinant glycan binding proteins and its use. The present disclosure provides a modified prote... |
|
|
Invention
|
Protein compositions for the treatment of inflammatory diseases.
The present invention relates t... |
|
|
Invention
|
Protein compositions for the treatment of inflammatory diseases. The present invention relates to... |
|
|
Invention
|
Recombinant proteins, compositions and methods of stabilization thereof.
The present invention r... |
|
|
Invention
|
Recombinant proteins, compositions and methods of stabilization thereof. The present invention re... |
|
|
Invention
|
Lectin protein for treatment and prevention of neurodegenerative diseases.
The present invention... |
|
|
Invention
|
Lectin protein for treatment and prevention of neurodegenerative diseases. Sclerotium rolfsiiScle... |
|
2021
|
Invention
|
Substituted tricyclic compounds.
The invention provides a compound of formula (I) or a pharmaceu... |
|
|
Invention
|
Substituted tricyclic compounds. 11 is –NRaRb211010 alkyl group; Raand Rb11010 alkyl group, and u... |
|
|
Invention
|
Process for the preparation of rivaroxaban involving novel intermediate. The present invention re... |
|
|
Invention
|
Anti-cancer proteins.
A recombinant lectin for use in a method of treatment of cancer by inhibit... |
|
|
Invention
|
Anti-cancer proteins. A recombinant lectin for use in a method of treatment of cancer by inhibiti... |
|
2020
|
Invention
|
Stable formulations of recombinant proteins.
The present invention relates to stable formulation... |
|
|
Invention
|
Stable formulations of recombinant proteins. Sclerotium rolfsii Sclerotium rolfsiiSclerotium rolf... |
|
|
Invention
|
Novel process for the preparation of filgotinib and intermediates thereof.
The present invention... |
|
|
Invention
|
Novel process for the preparation of filgotinib and intermediates thereof. The present invention ... |
|
|
Invention
|
Extended release composition of tofacitinib.
The present disclosure provides an extended release... |
|
|
Invention
|
Extended release composition of tofacitinib. The present disclosure provides an extended release ... |
|
2019
|
Invention
|
Combination of chemotherapy with recombinant s. rolfsii lectin.
The present invention relates to... |
|
|
Invention
|
Combination of chemotherapy with recombinant s. rolfsii lectin. The present invention relates to ... |
|
|
Invention
|
Protein for treatment of inflammatory diseases. The present invention relates to a lectin for use... |
|
|
Invention
|
Process for the preparation of recombinant lectin protein. The present invention relates to the p... |
|
|
Invention
|
An improved process for the preparation of recombinant lectin protein. The present invention rela... |
|
|
Invention
|
Recombinant lectin variants. A modified lectin protein is provided having at least one amino acid... |
|
|
Invention
|
Leader sequence for higher expression of recombinant proteins.
The present invention relates to ... |
|
|
Invention
|
Leader sequence for higher expression of recombinant proteins. The present invention relates to t... |
|
|
Invention
|
An enzymatic process for the preparation of (r)-sitagliptin. The present invention relates to an ... |
|
2018
|
Invention
|
Nucleotide sequences encoding 3-quinuclidinone reductase and glucose dehydrogenase and soluble ex... |
|
|
Invention
|
Process for the preparation of opicapone and intermediates thereof.
The present invention is rel... |
|
|
Invention
|
Pharmaceutical compositions of apremilast. The present invention relates to a disintegrant free p... |
|
|
Invention
|
Highly efficient enzymatic process to produce (r)-3-quinuclidinol.
The present invention relates... |
|
|
Invention
|
Pharmaceutical compositions comprising cinacalcet hydrochloride and one or more binders. 10 equal... |
|
|
Invention
|
Process to prepare n-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulphonyl) ethyl]-1, 3-dioxo-... |
|
|
Invention
|
Process for preparation and purification of vortioxetine hydrobromide. The present invention is r... |
|
|
Invention
|
Bioequivalent pharmaceutical composition of vortioxetine hydrobromide. The invention relates to v... |
|
|
Invention
|
Pharmaceutical composition of apixaban. 90 particle size of more than 100 microns, preferably bet... |
